Daewoong Pharmaceutical Conducts ESG Medical Volunteer Service in Daebudo

Daewoong Pharmaceutical is expanding its ESG (Environmental, Social, and Governance) management practices through medical volunteer activities that incorporate advanced digital healthcare technologies.

On August 20, Daewoong Pharmaceutical announced that it had conducted an 'ESG Digital Health Medical Volunteer Service' for 76 residents of Daebunam-dong Senior Center in Ansan, Gyeonggi Province, who are underserved in terms of healthcare access.

A resident of Daebudo is checking the fundus condition using the AI real-name disease diagnosis solution "Whiskey" and the fundus camera "Optina Genesis." Photo by Daewoong Pharmaceutical

Daebudo, due to its rural and island characteristics, has a relatively high proportion of elderly residents compared to urban areas. With only one public health center on the island and no other medical institutions, residents face significant challenges in receiving regular health checkups and managing chronic diseases.

This volunteer service marks the second medical outreach to an island region, following Yukdo in June. It is significant in that it provides practical health management opportunities through digital health technologies, while also realizing both healthcare equity and ESG values. The medical volunteer team, composed of Daewoong Pharmaceutical and six digital health companies (Seers Technology, ARK, ExoSystems, A-Sleep, EverEx, and MedicalAI), visited the Daebunam-dong Senior Center despite the sweltering 38-degree heat, working to address healthcare blind spots.

The main devices used included: ▲ the AI real-name disease diagnosis solution "Whiskey" and the fundus camera "Optina Genesis," ▲ the wearable electrocardiogram device "Mobicare," ▲ the early heart failure diagnosis software "ETIA LVSD," ▲ the sarcopenia analysis solution "ExoMed-DeepSarc," ▲ the musculoskeletal analysis software "Mora View," and ▲ the sleep apnea diagnosis app "AppnoTrack."

On-site screening using digital healthcare devices identified a significant number of residents requiring further attention. The AI fundus examination (Whiskey and Optina) found that about 40% of residents showed suspected signs of vision-threatening diseases. The sarcopenia test (ExoMed-DeepSarc) classified approximately 48% as being in the suspicious or cautionary stage, recommending detailed examinations. Additionally, the musculoskeletal test (Mora View) revealed postural misalignment in about 65% of participants, leading to on-site guidance for customized exercises.

This volunteer service was especially meaningful because Daebudo residents, who have difficulty accessing hospitals, were able to go beyond simple blood pressure or blood sugar measurements. They could use the latest digital healthcare technologies-normally hard to access-to identify potential health risks in advance and receive guidance on necessary lifestyle improvements. In particular, it was significant that diseases often missed in routine checkups, such as heart failure, arrhythmia, sarcopenia, and sleep apnea, could be detected early.

Ultimately, this initiative is gaining attention as a digital health-based model that can make a tangible contribution to closing healthcare gaps by enabling early detection and prevention-focused management of chronic diseases. It is a direct example of implementing the ESG value of "bridging healthcare disparities with digital technology" in the field.

Daewoong Pharmaceutical plans to continue collaborating with various medical device companies to provide regular health support activities for underserved populations, while also contributing to the development of the domestic digital health ecosystem through data-driven precision health management models.

Cho Byungha, Head of Digital Healthcare at Daewoong Pharmaceutical, stated, "This volunteer service is part of Daewoong Pharmaceutical's ESG management practices aimed at creating a 'world where everyone is healthy.' We will continue to promote mutual growth with local communities through digital healthcare technologies and consistently support areas with limited access to medical care."

This content was produced with the assistance of AI translation services.